Waldemar Hoffmann is the CEO and Co-Founder of Apersys AG as of January 2024, and a member of the Board of Directors. Prior to this role, Hoffmann served as Project Leader for Liver4Life at Wyss Zurich until April 2025, and held positions at vVARDIS from April 2021 to October 2022, where responsibilities included leading R&D Project Management and improving project delivery efficiency. Significant prior experience includes senior roles at Nobel Biocare, overseeing R&D management for regeneratives and biologics, and leading cross-functional collaborations. Hoffmann’s educational background includes a PhD in Bioengineering and Biomedical Engineering from the University of Basel and a Diplom Ingenieur from the Karlsruhe Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices